Over the years, alternatives to Protein A chromatography capture column in the monoclonal antibody platform process have been explored with varying degrees of success. Among those alternatives, cation exchange chromatography (CEX) has been widely reported as an alternative to protein A as a capture column. Conventional CEX resins, however, have low selectivity for antibodies in clarified cell culture media under typical media conductivities. Therefore, achieving reasonable binding to the CEX capture column requires either dilution of the feed, a concentration/diafiltration step, or pH adjustment prior to loading. Careful control of feed concentration, buffer composition, and pH prior to CEX capture can help optimize performance of the resins under these conditions.
In this webinar, Advanced Instruments in partnership with Jefferson Institute for Bioprocessing will discuss the evaluation of the impact of monitoring osmolality during an ultrafiltration/diafiltration (UF/DF) step prior to CEX capture of monoclonal antibodies from mammalian cell cultures. This was compared with conductivity monitoring to build a model based on osmolality measurements.
Thiago Millen, Lead Scientist, Jefferson Institute for Bioprocessing (JIB)
Thiago Millen is the Lead Scientist at Jefferson Institute for Bioprocessing (JIB), with a broad background in downstream process development. Since 2008, he has worked at fast-paced biotech startups and in a large pharmaceutical company. He has experience in optimizing protein expression and developing multi-step purification strategies for antibodies and other therapeutic proteins, and performing protein analytics to support process characterization studies.
Who Should Attend?
This webinar will appeal to professionals involved with:
- Downstream processes
- UF/DF processes
- Biologic bio-manufacturing
- Downstream process development
- Process development
- Process development buffer exchange
- Bioprocess, including: process development scientists & downstream process engineers
What You Will Learn
Join this webinar to learn more about:
- The evaluation of the impact of monitoring osmolality during an UF/DF step prior to CEX capture of monoclonal antibodies from mammalian cell cultures
- A comparison with conductivity monitoring to build a model based on osmolality measurements
Advanced Instruments is a global company offering a novel portfolio of analytical tools including, OsmoTECH®, a robust line of micro-osmometers to support bioprocessing and quality control (QC), and Solentim, a portfolio of best in class imaging and single-cell deposition technologies for cell line development workflows and assurance of clonality for regulatory bodies.